Sat, Aug 23, 2014, 8:05 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

this_isnt_my_real_alias 30 posts  |  Last Activity: Aug 21, 2014 9:30 AM Member since: Dec 28, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    That is a massive drop for 2 days

    by cosmic_cow_of_mystery Jul 8, 2014 11:13 AM
    this_isnt_my_real_alias this_isnt_my_real_alias Jul 8, 2014 1:04 PM Flag

    Right now PACB is following the same action as ILMN. Looks like some profit-takers scared weak hands into following suit.

  • Reply to

    That is a massive drop for 2 days

    by cosmic_cow_of_mystery Jul 8, 2014 11:13 AM
    this_isnt_my_real_alias this_isnt_my_real_alias Jul 8, 2014 12:58 PM Flag

    It's not very hard to shake some people loose. Many times you see this kind of action just previous to a good run. Just have to wait and see.

  • Reply to

    Huge AH volume

    by koloric Jun 27, 2014 4:47 PM
    this_isnt_my_real_alias this_isnt_my_real_alias Jun 28, 2014 2:41 AM Flag

    nimumu Are you for real ? The company is NOT selling stock on the "open" market, what you you are posting is past financing activities.

    Do you seriously think the company can sell MILLIONS of shares in one day on the open market.......and the stock only goes down......20 CENTS ?

    Go back to the GTAT message board where they scoffed at you there also.

  • Reply to

    Huge AH volume

    by koloric Jun 27, 2014 4:47 PM
    this_isnt_my_real_alias this_isnt_my_real_alias Jun 27, 2014 10:38 PM Flag

    nimuma......"Pacbio dumping shares to get cash is a fact. Do your own dd."

    Show me that......"fact".

  • Reply to

    Huge AH volume

    by koloric Jun 27, 2014 4:47 PM
    this_isnt_my_real_alias this_isnt_my_real_alias Jun 27, 2014 8:16 PM Flag

    nimuma.......First you say....."My guess is Pacbio was dumping shares in the open market these days to get more cash."

    Then you go on to say......."they have been doing that for many monthes."

    My question to you is, how long have you been in the guessing game ? And have any of your guesse ever been correct ? And if so, can you point to any, or even one of them that have been correct.

    And please, don't guess at how many times you have been correct.

    Just the facts please, just the facts.

  • this_isnt_my_real_alias by this_isnt_my_real_alias Jun 23, 2014 1:05 AM Flag

    Sells stock.........but there is only one reason an insider buys stock, and it's not because the insider thinks the stock will be heading down

    Not to mention that this particular 114,000 share buy, by an insider........could have been acquired at a much lower price than it was bought at........just a matter of days before his buy.

    Patience here will be handsomely rewarded.

  • this_isnt_my_real_alias by this_isnt_my_real_alias Jun 20, 2014 4:08 PM Flag

    64,879 Share Buy At $6.49..... at time 16:00 EST.

    Very good demand for the stock.

  • this_isnt_my_real_alias by this_isnt_my_real_alias Jun 19, 2014 9:34 PM Flag

    MRK Buying IDIX even though IDIX has collaborations with....."The company has a collaboration agreement with Janssen Pharmaceuticals, Inc.; Novartis Pharma AG; ViiV Healthcare Company; and GlaxoSmithKline."

    So don't think that just because Roche bought Genia, that that will stop any other company from scooping up PACB.

    And look at how much MRK is paying for IDIX., Friday 6/6/14 IDIX closed at $7.23. Monday 6/9/14 IDIX closed at $23.79, on the announcement.

  • this_isnt_my_real_alias by this_isnt_my_real_alias Jun 19, 2014 2:25 PM Flag

    June 19, 2014

    Pacific Biosciences and GenDx Initiate Co-marketing Activities for Full-Length HLA Gene Sequencing Products

    UTRECHT, The Netherlands and MENLO PARK, California, USA — June 19, 2014 — Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, and GenDx, a pioneer in the area of sequence-based typing and next-generation sequencing for HLA typing, today announced a co-marketing agreement to offer products for full-length HLA gene sequencing.

    The Human Leukocyte Antigen (HLA) system consists of a large family of highly variable genes and allelic variants that forms the basis of the human immune system. High-resolution HLA typing and sequencing of the complete gene enables determination of even the smallest variations between HLA alleles.HLA allele-specific genotyping is critical for autoimmune disease-association studies, drug hypersensitivity research and other applications. Thus, there has been an ever growing interest in characterizing the HLA genes in their entirety.



    GenDx, which currently offers reagents for the amplification of full-length, Class I HLA genes, will offer a version of its NGSgo® reagent line with barcoded primers developed with Pacific Biosciences for sequencing on the PacBio RS II DNA sequencing system. Using the GenDx NGSengine software package to analyze data from the PacBio system provides customers with a highly accurate, allele-level HLA typing solution. This new reagent kit will allow the pooling of full-length, Class I HLA genes from multiple samples into a single sequencing run. More information about the new solution and ordering information can be found at

  • this_isnt_my_real_alias by this_isnt_my_real_alias Jun 18, 2014 2:34 AM Flag

    The chart looks real good, higher daily lows, and volume tapering off.

    Sellers are mostly dissipating at this price range.

    For some reason not been able to post now for about three or four weeks.....anybody else having that problem? The way this message board looks, I'm thinking a lot of posters are also unable to post. I'm surprised I'm able to post this. Have not been able to post, rate anybody elses post, or anything at all.

EXEL
4.11+0.02(+0.49%)Aug 22 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.